209 related articles for article (PubMed ID: 19086816)
1. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm.
Margarit I; Rinaudo CD; Galeotti CL; Maione D; Ghezzo C; Buttazzoni E; Rosini R; Runci Y; Mora M; Buccato S; Pagani M; Tresoldi E; Berardi A; Creti R; Baker CJ; Telford JL; Grandi G
J Infect Dis; 2009 Jan; 199(1):108-15. PubMed ID: 19086816
[TBL] [Abstract][Full Text] [Related]
2. Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease.
Buccato S; Maione D; Rinaudo CD; Volpini G; Taddei AR; Rosini R; Telford JL; Grandi G; Margarit I
J Infect Dis; 2006 Aug; 194(3):331-40. PubMed ID: 16826481
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae.
Rosini R; Rinaudo CD; Soriani M; Lauer P; Mora M; Maione D; Taddei A; Santi I; Ghezzo C; Brettoni C; Buccato S; Margarit I; Grandi G; Telford JL
Mol Microbiol; 2006 Jul; 61(1):126-41. PubMed ID: 16824100
[TBL] [Abstract][Full Text] [Related]
4. Distribution of pilus islands and alpha-like protein genes of group B Streptococcus colonized in pregnant women in Beijing, China.
Lu B; Wang D; Zhou H; Zhu F; Li D; Zhang S; Shi Y; Cui Y; Huang L; Wu H
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1173-9. PubMed ID: 25669160
[TBL] [Abstract][Full Text] [Related]
5. Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa.
Madzivhandila M; Adrian PV; Cutland CL; Kuwanda L; Madhi SA; The PoPS Trial Team
J Med Microbiol; 2013 Feb; 62(Pt 2):249-253. PubMed ID: 23065545
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.
Paoletti LC; Pinel J; Johnson KD; Reinap B; Ross RA; Kasper DL
J Infect Dis; 1999 Sep; 180(3):892-5. PubMed ID: 10438388
[TBL] [Abstract][Full Text] [Related]
7. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
[TBL] [Abstract][Full Text] [Related]
8. Genetic evidence for a novel variant of the pilus island 1 backbone protein in group B Streptococcus.
Teatero S; Neemuchwala A; Yang K; Gomes J; Athey TBT; Martin I; Demczuk W; McGeer A; Fittipaldi N
J Med Microbiol; 2017 Oct; 66(10):1409-1415. PubMed ID: 28923133
[TBL] [Abstract][Full Text] [Related]
9. [Distribution and genetic organization of the pathogenicity island XII among the clinical strains of GBS].
Kuleshevich EV; Savicheva AM; Arzhanova ON; Suvorov AN
Mol Gen Mikrobiol Virusol; 2013; (1):26-30. PubMed ID: 23785787
[TBL] [Abstract][Full Text] [Related]
10. Biofilm production and distribution of pilus variants among
Alvim DCSS; Ferreira AFM; Leal MA; Oliveira LMA; Botelho AMN; Botelho ACN; Figueiredo AMS; Fracalanzza SEL; Teixeira LM; Pinto TCA
Biofouling; 2019 Sep; 35(8):938-944. PubMed ID: 31646898
[No Abstract] [Full Text] [Related]
11. Epidemiology of Streptococcus agalactiae colonization in Germany.
Brimil N; Barthell E; Heindrichs U; Kuhn M; Lütticken R; Spellerberg B
Int J Med Microbiol; 2006 Feb; 296(1):39-44. PubMed ID: 16361113
[TBL] [Abstract][Full Text] [Related]
12. Conjugate vaccines against group B Streptococcus types IV and VII.
Paoletti LC; Kasper DL
J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
[TBL] [Abstract][Full Text] [Related]
13. Phylogeny, recombination, and invasiveness of group B Streptococcus revealed by genomic comparisons of its global strains.
Lin E; Zou S; Wang Y; Lee CC; Chiu CH; Feng Y
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):581-590. PubMed ID: 33067737
[TBL] [Abstract][Full Text] [Related]
14. Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups.
Zhao Z; Kong F; Zeng X; Gidding HF; Morgan J; Gilbert GL
Clin Microbiol Infect; 2008 Mar; 14(3):260-7. PubMed ID: 18190584
[TBL] [Abstract][Full Text] [Related]
15. BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus.
Santi I; Maione D; Galeotti CL; Grandi G; Telford JL; Soriani M
J Infect Dis; 2009 Aug; 200(4):564-70. PubMed ID: 19586417
[TBL] [Abstract][Full Text] [Related]
16. Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany.
Fluegge K; Supper S; Siedler A; Berner R
Clin Infect Dis; 2005 Mar; 40(5):760-3. PubMed ID: 15714426
[TBL] [Abstract][Full Text] [Related]
17. Early-onset group B streptococcal disease in the era of maternal screening.
Puopolo KM; Madoff LC; Eichenwald EC
Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
[TBL] [Abstract][Full Text] [Related]
18. Role of pilus proteins in adherence and invasion of Streptococcus agalactiae to the lung and cervical epithelial cells.
Sharma P; Lata H; Arya DK; Kashyap AK; Kumar H; Dua M; Ali A; Johri AK
J Biol Chem; 2013 Feb; 288(6):4023-34. PubMed ID: 23209289
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of serotypes distribution of group B streptococci origin from pregnant carriage using multiplex PCR].
Brzychczy-Włoch M; Gosiewski T; Bodaszewska M; Pabian W; Bulanda M; Heczko PB
Med Dosw Mikrobiol; 2009; 61(4):293-9. PubMed ID: 20201318
[TBL] [Abstract][Full Text] [Related]
20. Distribution of pilus islands in Streptococcus agalactiae that cause human infections: insights into evolution and implication for vaccine development.
Martins ER; Andreu A; Melo-Cristino J; Ramirez M
Clin Vaccine Immunol; 2013 Feb; 20(2):313-6. PubMed ID: 23269415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
